Skip links

Regulatory briefing

Where in the world are the countries most likely to legalise cannabis?

Written by Barnaby Page || 17th January 2019 || Regulatory briefing |

Africa
Asia
Australasia
Canada
Europe
Mexico
New Zealand
North America
South America
United States
World
Policy and Politics
Regulation and Legislation
Regulatory briefing
Researchers in Portugal have developed an algorithm to identify characteristics that suggest the nations most likely to legalise recreational cannabis ...

Is FDA taking action on CBD products ‘for human consumption’?

Written by Freddie Dawson || 17th January 2019 || Regulatory briefing |

North America
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
An unconfirmed seizure of products from a shop in Arizona could be the first instance of enforcement on CBD by Food and Drug Administration (FDA) officials since the passage of the US 2018 Farm Bill ...

New Congress, new outlook for the legal status of cannabis

Written by CBD-Intel || 3rd January 2019 || Regulatory briefing |

Canada
North America
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
The US Congress is expected to address the legal situation of CBD and cannabis during the upcoming congressional session, according to a number of experts interviewed by CBD-Intel ...

New York state sets out new rules for manufacture of CBD products

Written by Freddie Dawson || 17th December 2018 || Regulatory briefing |

New York
North America
United States
Regulation and Legislation
Regulatory briefing
New York state has set out a series of new regulatory requirements for businesses wanting to produce or sell CBD products in its jurisdiction, with strict manufacturing, reporting and product category guidelines ...

Congress passes US Farm Bill with Hemp Farming Act intact

Written by Daniel Mollenkamp || 14th December 2018 || Regulatory briefing |

North America
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
The US Congress has approved a compromise version of the 2018 Farm Bill which will remove industrial hemp from the federal narcotics Schedule 1 list, potentially giving a green light to development of the CBD industry ...

What will Brexit really mean for the British CBD industry?

Written by CBD-Intel || 19th November 2018 || Regulatory briefing |

EU
Europe
United Kingdom
Policy and Politics
Regulation and Legislation
Regulatory briefing
The British government last week presented the 585-page draft withdrawal agreement which lays out how it intends the UK to leave the European Union. Here CBD-Intel explains just how it may affect the CBD industry ...

Michigan says yes, North Dakota says no to recreational cannabis

Written by Daniel Mollenkamp || 7th November 2018 || Regulatory briefing |

North America
United States
Regulation and Legislation
Regulatory briefing
Voters in Michigan have voted to legalise the recreational use of cannabis, while those in North Dakota rejected it. In Utah and Missouri medical cannabis use was approved on the day the US turned out to vote in...

Cannabis in the UK now medically legal – up to a point

Written by Freddie Dawson || 1st November 2018 || Regulatory briefing |

Europe
United Kingdom
Regulation and Legislation
Regulatory briefing
Medical cannabis products are now legal in the UK – in very limited circumstances. This could include products without marketing authorisation, if approved by a registered specialist in certain conditions ...

Canada learning early lessons in enforcement after legalisation

Written by Freddie Dawson || 26th October 2018 || Regulatory briefing |

Canada
North America
Regulatory briefing
The legalisation of Cannabis farming and commercialisation that became effective last week has created a new dynamic legal market for high- and low-THC cannabis strains and by-products in Canada, such as food products or e-liquids. One week after the...

Hemp still on federal narcotics list as Congressional deadline lapses

Written by Daniel Mollenkamp || 8th October 2018 || Regulatory briefing |

North America
United States
Policy and Politics
Regulation and Legislation
Regulatory briefing
A deadline for the federal legislature to pass a bill expected to remove hemp and low-THC cannabis from the federal list of narcotics lapsed on 30th September, leaving US hemp farmers in regulatory uncertainty ...

CBD medicines for animals will need UK government approval

Written by Barnaby Page || 26th September 2018 || Regulatory briefing |

EU
Europe
United Kingdom
Regulation and Legislation
Regulatory briefing
CBD-based medical treatments for animals will need government approval before being sold in the UK, after the country’s Veterinary Medicines Directorate (VMD) decided they fall under the definition of veterinary medicines ...

Experiments on mice suggest you can’t get addicted to CBD

Written by Marc Beishon || 23rd August 2018 || Regulatory briefing |

Europe
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
A new series of animal studies purports to show that CBD is non-addictive – potentially clearing the way for further research into the mechanisms behind its possible beneficial qualities ...

French warnings over ‘stores likely to be selling illegal products’

Written by David Palacios || 17th August 2018 || Regulatory briefing |

Europe
France
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
Judicial bodies in France have issued statements clarifying the national legal framework for products containing cannabidiol (CBD) and asked local enforcement authorities to ensure compliance with current legislation ...

US authorities call into question the legality of CBD

Written by CBD-Intel || 8th June 2018 || Regulatory briefing |

North America
United States
Policy and Politics
Public Health and Medicine
Regulation and Legislation
Regulatory briefing
US government agencies have questioned the legality of cannabidiol (CBD) – just as the industry is starting to benefit from increased public awareness ...